Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8668405 | Journal of Clinical Lipidology | 2018 | 10 Pages |
Abstract
This Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglycerides and Impact on Global Health Outcomes trial post hoc substudy indicates that inflammation, as indexed by GlycA, is unaffected by ERN treatment but is significantly associated with the residual risk of CVD and death in patients treated to low levels of LDL cholesterol.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
James D. PhD, John R. MD, Margery A. PhD, MBA, Sydney PhD, Vera MD, MSPH, Steven L. MD, Megan MS, Santica M. PhD, DSc, Joseph B. MD, William E. MD,